The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs
FDA Law Blog
APRIL 8, 2025
As folks steeped in the world of generic drugs And Hatch-Waxman know, theres a lot that happens before FDA can take action on an ANDA. Leading FDAs implementationof the Drug Competition Action Plan (DCAP). Overseeing the development, clearance, and issuance of every policy document FDA issued on generic drugs.
Let's personalize your content